Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 608.00
Bid: 610.00
Ask: 616.00
Change: 0.00 (0.00%)
Spread: 6.00 (0.984%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 608.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

20 Apr 2021 07:00

RNS Number : 9522V
Porvair PLC
20 April 2021
 

FOR IMMEDIATE RELEASE 20 April 2021

 

 

 Porvair plc

 

AGM Trading Update

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, will make the following trading update today at its Annual General Meeting:

In the four months ended 31 March 2021, the Group has performed better than management expected at the time of the preliminary results in February 2021, with revenue 6% lower (4% in constant currency) than the comparative period in the last financial year.

While aerospace activity remained subdued, other parts of the business started to see stronger demand. Revenue in the first four months of this financial year was 12.5% ahead (at constant currency) of the final four months of the 2020 financial year. Management is encouraged that adjusted operating profit for the first four months is in line with a strong 2020 comparator.

Looking ahead, the Aerospace & Industrial division is still suffering from lower aerospace demand, although recent order intake suggests that activity may pick up in the second half. The Laboratory division has started the year strongly, helped by Covid-19 related activities. The Metal Melt Quality division is benefitting from a reduced cost base and an improving performance in China. Demand in the last few weeks has been stronger in the US.

The Group will announce its interim results for the six months ending 31 May 2021 on Monday 5 July 2021.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

 

Chris Tyler, Group Finance Director

 

 

 

Buchanan Communications

0207 466 5000

Charles Ryland / Steph Watson

 

 

Notes to Editors:

Porvair is a group of specialist filtration, separation, laboratory and environmental technologies businesses. Its products are used in a range of niche filtration and separation markets and are derived from its expertise in the design and manufacture of filtration and separation systems. It is organised into three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKLNFSDFEFA
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.